PMC:7311890 / 22873-23093
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T168 | 161-163 | Body_part | denotes | A1 | http://purl.org/sig/ont/fma/fma66592 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T114 | 81-89 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T217 | 157-163 | http://purl.obolibrary.org/obo/CLO_0053413 | denotes | apo-A1 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 647 | 157-163 | Gene | denotes | apo-A1 | Gene:335 |
| 690 | 73-77 | Disease | denotes | HDLs | MESH:C538394 |
| 691 | 81-89 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T154 | 0-220 | Sentence | denotes | Changes in phospholipidome therefore suggested reductions in circulating HDLs as COVID-19 progresses, which was in agreement with the observed reductions in apo-A1 (p = 0.0687) as disease severity increases (Figure S1C). |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T482 | 11-26 | CHEBI:16247;CHEBI:16247 | denotes | phospholipidome |
| T483 | 81-89 | SP_7 | denotes | COVID-19 |
| T32087 | 3-11 | SP_7 | denotes | nges in |
| T24069 | 75-81 | UBERON:0001969 | denotes | Ls as |
| T41089 | 82-90 | CHEBI:25212;CHEBI:25212 | denotes | OVID-19 |
| T98256 | 114-122 | SP_7 | denotes | agreeme |